Immunotherapy with a fel d 1-standardized depot allergen from feline skin scales is clinically efficacious in respiratory cat allergy

被引：0

|

作者：

Sprung, V ^{[1
]}

Meyer, H. ^{[1
]}

Cromwell, O. ^{[1
]}

Annemie, N. ^{[1
]}

机构：

[1] Allergopharma Joachim Ganzer KG, Clin Res & Dev, Reinbek, Germany

来源：

ALLERGY | 2008年 / 63卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

620

引用

收藏

页码：240 / 240

页数：1

相关论文

共 23 条

[21] FOLLOW ON STUDY OF THE FIRST CLINICAL-TRIAL WITH T-CELL DEFINED PEPTIDES FROM CAT ALLERGEN FEL-D-1
NORMAN, PS
OHMAN, JL
LONG, AA
CRETICOS, PS
GEFTER, ML
SHAKED, Z
WOOD, RA
EGGLESTON, PA
LICHTENSTEIN, LM
JONES, NH
NICODEMUS, CF
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (01) : 259 - 259
[22] Persistent Treatment Effect Achieved at One Year After 4 Doses of Fel d 1-Derived Peptide Immunotherapy in an Environmental Exposure Chamber (EEC) Model of Cat Allergy
Hafner, R. P.
Efthimiou, J.
Salapatek, A.
Patel, D.
Larche, M.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB144 - AB144
[23] Fel d 1-derived T cell peptide therapy induces recruitment of CD4+CD25+;: CD4+ interferon-γ+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects
Alexander, C
Ying, S
Kay, AB
Larché, M
CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (01): : 52 - 58